Table 2.
Medical variables at baseline and after Post12week HIIT intervention
| variables | Sub-variables | HIIT | Control | ||||
|---|---|---|---|---|---|---|---|
| Baseline | Post12week | p value | Baseline | Post12week | p value | ||
| Glycemic parameters | FPG (mg·dL–1) | 163.32 ± 51.37 | 131.28 ± 43.11* | 0.001* | 159.17 ± 43.43 | 157.28 ± 43.11 | 0.765 |
| PPG (mg·dL–1) | 180.33 ± 59.03 | 146.76 ± 65.73* | 0.001* | 176.29 ± 43.15 | 178.40 ± 35.19 | 0.664 | |
| HbA1c (%) | 7.66 ± 1.15 | 7.12 ± 1.37* | 0.021* | 7.60 ± 1.81 | 7.57 ± 1.39 | 0.834 | |
| Lipid profile | TC (mg·dL–1) | 176.09 ± 43.71 | 153.27 ± 54.36* | 0.001* | 175.64 ± 23.42 | 176.29 ± 35.44 | 0.845 |
| HDL-Chl (mg·dL–1) | 50.42 ± 6.25 | 47.93 ± 7.04 | 0.452 | 52.29 ± 7.83 | 51.12 ± 8.15 | 0.769 | |
| LDL-Chl (mg·dL–1) | 108.77 ± 20.03 | 104.25 ± 36.18 | 0.649 | 107.37 ± 16.97 | 108.36 ± 20.37 | 0.902 | |
| TG (mg·dL–1) | 157.90 ± 86.62 | 127.75 ± 68.71* | 0.001* | 155.52 ± 72.15 | 154.71 ± 80.46 | 0.712 | |
| Kidney function markers | Na (mEq·L–1) | 145.45 ± 3.25 | 122.46 ± 23.12* | 0.001* | 147.23 ± 15.37 | 145.81 ± 17.83 | 0.693 |
| K (mEq·L–1) | 4.55 ± 1.04 | 4.40 ± 1.37 | 0.824 | 4.49 ± 1.08 | 4.50 ± 1.25 | 0.866 | |
| Urea (mg·dL–1) | 37.23 ± 9.91 | 36.9 ± 6.14 | 0.796 | 37.17 ± 8.67 | 37.73 ± 8.42 | 0.648 | |
| PCr (mg·dL–1) | 0.93 ± 0.09 | 0.91 ± 0.12 | 0.826 | 0.93 ± 0.25 | 0.92 ± 0.46 | 0.798 | |
| Liver function markers | AST (U·L–1) | 13.55 ± 6.76 | 13.29 ± 7.63 | 0.834 | 14.01 ± 8.22 | 13.92 ± 7.29 | 0.692 |
| ALT (U·L–1) | 32.46 ± 25.13 | 31.4 ± 53.03 | 0.789 | 33.08 ± 15.17 | 32.9 ± 26.91 | 0.792 | |
| γ-GT (U·L–1) | 33.16 ± 25.67 | 30.12 ± 35.11 | 0.124 | 32.57 ± 48.38 | 33.61 ± 53.72 | 0.802 | |
| CK (U·L–1) | 220.12 ± 153.03 | 114.20 ± 126.17* | 0.001* | 218.31 ± 99.65 | 222.15 ± 100.60 | 0.697 | |
| ALP (U·L–1) | 111.49 ± 26.73 | 103.56 ± 27.73* | 0.026* | 109.55 ± 36.27 | 108.80 ± 45.53 | 0.795 | |
| Hematological profile | RBC (×106·mm–3) | 5.01 ± 1.03 | 4.90 ± 1.15 | 0.297 | 5.10 ± 1.22 | 5.03 ± 2.01 | 0.625 |
| Hgb (g%) | 14.73 ± 2.05 | 14.43 ± 2.11 | 0.756 | 13.96 ± 2.67 | 14.26 ± 2.52 | 0.789 | |
| Hct (%) | 45.07 ± 3.99 | 40.47 ± 4.27* | 0.001* | 43.44 ± 5.08 | 42.73 ± 4.90 | 0.802 | |
| Hormones | TSH (mU·L–1) | 1.50 ± 1.19 | 1.55 ± 1.73 | 0.634 | 1.49 ± 0.87 | 1.52 ± 0.98 | 0.630 |
| Cortisol (μg·dL–1) | 14.17 ± 4.23 | 10.17 ± 4.46* | 0.001* | 13.73 ± 4.34 | 13.60 ± 4.76 | 0.856 | |
*=P < 0.05 considered statistically significant. Values are expressed as means ± SD. ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; TC, plasma total cholesterol; CK, creatine kinase; FPG, fasting plasma glucose; g-GT, g-glutamyl transferase; HbA1c, hemoglobin A1c; Hct, hematocrit; HDL, high-density lipoprotein; Hgb, hemoglobin; LDL, low-density lipoprotein; PCr, plasma creatinine; PPG, postprandial plasma glucose; RBC, red blood cells; TG, plasma triglyceride; TSH, thyroid-stimulating hormone